PEG3 inhibits mitophagy of papillary thyroid carcinoma through ISG15/VCP axis
Authors:
Open Access
- 8 August 2026
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 83 (1)
Abstract
Interferon-stimulated gene 15 (ISG15) is an essential biomarker in several cancers. However, the molecular mechanism of ISG15 regulating thyroid carcinoma (THCA) has rarely been studied. In our study, papillary thyroid carcinoma cell lines of TPC-1 and IHH-4, clinical samples of THCA, and nude mice were employed. The expression levels of genes were tested by real-time quantitative PCR and western blotting analyses. Cell activity was assessed using cell counting kit-8 assay and colony formation assays. Flow cytometry measured the ROS level and mitochondrial membrane potential. To induce mitophagy, cells were treated with 10µM CCCP (Carbonyl Cyanide m-Chlorophenylhydrazone) for 6 h. The level of mitophagy was assessed by transmission electron microscopy, LC3B-TOMM20 co-localization, mitochondrial Parkin level, p-S65-Ub and related protein expression. Co-immunoprecipitation assays determined the binding relationship between ISG15 and VCP. Chromatin immunoprecipitation, electrophoretic mobility shift and dual-luciferase reporter assay measured the targeting of PEG3 on the ISG15 promoter. Our results showed that ISG15 was highly expressed in THCA. ISG15 overexpression promoted cell proliferation and mitophagy. Mechanistically, ISG15 bound to VCP and promoted its stability. VCP integrated with ISG15 to promote cell viability, and mitophagy. Further experiments revealed that PEG3, which acted as a transcriptional inhibitor of ISG15, exerted an effect opposing that of ISG15. The role of ISG15 and PEG3 were also confirmed in xenograft mice model. In conclusion, our present study explored the molecular mechanism of ISG15 on THCA and found that PEG3 transcriptionally regulated ISG15 and promoted the proliferation and mitophagy of papillary thyroid carcinoma cells through VCP. Our present study revealed a novel mechanism of ISG15 on THCA, which might be a promising therapeutic target for THCA.Keywords
This publication has 43 references indexed in Scilit:
- Oncogenic mutation-driven metabolism-immunity regulatory axis: Potential prospects for thyroid cancer precision therapyBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025
- Targeting VCP potentiates immune checkpoint therapy for colorectal cancerCell Reports, 2023
- Epigenetic reactivation of PEG3 by EZH2 inhibitors suppresses renal clear cell carcinoma progressCellular Signalling, 2023
- ISG15 deficiency features a complex cellular phenotype that responds to treatment with itaconate and derivativesClinical and Translational Medicine, 2022
- A neutrophil-mediated carrier regulates tumor stemness by inhibiting autophagy to prevent postoperative triple-negative breast cancer recurrence and metastasisActa Biomaterialia, 2022
- ISG15 attenuates post-translational modifications of mitofusins and congression of damaged mitochondria in Ataxia Telangiectasia cellsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2021
- RETRACTED: Long noncoding RNA ZNF667‐AS1 reduces tumor invasion and metastasis in cervical cancer by counteracting microRNA‐93‐3p‐dependent PEG3 downregulationMolecular Oncology, 2019
- ISG15 in cancer: Beyond ubiquitin-like proteinCancer Letters, 2018
- Up-regulation of interferon-stimulated gene15 and its conjugates by tumor necrosis factor-α via type I interferon-dependent and -independent pathwaysMolecular and Cellular Biochemistry, 2012
- Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down‐regulated in human ovarian cancers by loss of heterozygosity and promoter methylationCancer, 2008